NASDAQ:MITO
Delisted

Stealth Biotherapeutics Stock News

etoro logo Buy MITO
*Your capital is at risk
$0.320
+0 (+0%)
At Close: Feb 14, 2023
NEEDHAM, Mass. , Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and commercia
NEEDHAM, Mass. , Aug. 18, 2025 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for disea
The U.S. Food and Drug Administration has asked for a resubmission of Stealth BioTherapeutics' marketing application for its experimental therapy targeting a rare genetic condition, Barth syndrome, th
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a rare genetic condition that typically affects boys, the drug developer
– New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –  – Follows Positive FDA Advisory Committee Meeting Vote Concluding that Elamipretide is Effective fo
Barth Syndrome is an Ultra-rare, Progressive, Life-Shortening, Cardioskeletal Disease that Affects Approximately 150 Individuals in the United States If Approved, Elamipretide Would Become the First A
NEEDHAM, Mass. , May 6, 2024 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercializati
Barth Syndrome is an Ultra-rare, Progressive, Life-Shortening, Cardioskeletal Disease that Affects Approximately 150 Individuals in the United States If Approved, Elamipretide Would Become the First A
NEEDHAM, Mass. , Dec. 4, 2023 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development, and commercializ
Here are three penny stocks to watch right now The post Good Penny Stocks to Buy Today? 3 to Watch Right Now  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Stealth BioTherapeutics Corp (NASDAQ: MITO) presented new SBT-272 preclinical data demonstrating functional improvement in upper motor neurons with TDP-43 pathology. TDP-43 pathology plays a signif

10 Biggest Price Target Changes For Monday

11:52am, Monday, 23'rd May 2022 Benzinga
Telsey Advisory Group reduced DICK'S Sporting Goods, Inc. (NYSE: DKS) price target from $153 to $125. Dick's Sporting shares rose 2.7% to $79.62 in pre-market trading. Piper Sandler lowered the pric
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology BridgeBio Pharma Inc 

What to Know About Buying Penny Stocks on May 10th

12:00pm, Tuesday, 10'th May 2022 PennyStocks
Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 10th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 10th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE